ورود به حساب

نام کاربری گذرواژه

گذرواژه را فراموش کردید؟ کلیک کنید

حساب کاربری ندارید؟ ساخت حساب

ساخت حساب کاربری

نام نام کاربری ایمیل شماره موبایل گذرواژه

برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید


09117307688
09117179751

در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید

دسترسی نامحدود

برای کاربرانی که ثبت نام کرده اند

ضمانت بازگشت وجه

درصورت عدم همخوانی توضیحات با کتاب

پشتیبانی

از ساعت 7 صبح تا 10 شب

دانلود کتاب Hematology Board Review: Blueprint Study Guide and Q&A (Book + Free App)

دانلود کتاب بررسی هیئت هماتولوژی: راهنمای مطالعه طرح و پرسش و پاسخ (کتاب + برنامه رایگان)

Hematology Board Review: Blueprint Study Guide and Q&A (Book + Free App)

مشخصات کتاب

Hematology Board Review: Blueprint Study Guide and Q&A (Book + Free App)

ویرایش: 1 
نویسندگان: , , ,   
سری:  
ISBN (شابک) : 0826137822, 9780826137821 
ناشر: Demos Medical 
سال نشر: 2018 
تعداد صفحات: 420 
زبان: English 
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) 
حجم فایل: 3 مگابایت 

قیمت کتاب (تومان) : 54,000



ثبت امتیاز به این کتاب

میانگین امتیاز به این کتاب :
       تعداد امتیاز دهندگان : 8


در صورت تبدیل فایل کتاب Hematology Board Review: Blueprint Study Guide and Q&A (Book + Free App) به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.

توجه داشته باشید کتاب بررسی هیئت هماتولوژی: راهنمای مطالعه طرح و پرسش و پاسخ (کتاب + برنامه رایگان) نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.


توضیحاتی در مورد کتاب بررسی هیئت هماتولوژی: راهنمای مطالعه طرح و پرسش و پاسخ (کتاب + برنامه رایگان)



بررسی هیئت هماتولوژی: راهنمای مطالعه طرح و پرسش


توضیحاتی درمورد کتاب به خارجی

Hematology Board Review: Blueprint Study Guide and Q&A is a concise, outline-based study guide covering all topics that appear on the Hematology Certification Exam. The book includes all topics listed in the American Board of Internal Medicine (ABIM) blueprint as essential material for the exam and highlights topic areas that are often found on the test.

For hematology and oncology fellows as well as practicing clinicians needing a refresher before taking MOC, this handy study guide provides succinct overviews of all blood disorders, syndromes and diseases with practice questions on the go. Each disorder or disease-based chapter provides the same structure for ease of use beginning with the epidemiology, and followed by the etiology and risk factors, signs and symptoms, diagnostic criteria, indications for treatment, prognostic factors, treatment recommendations, and special considerations. The authors provide the most accurate and up-to-date information, including well-established treatment regimens for a variety of blood disorders, including iron disorders, bone marrow failure syndromes, platelet and megakaryocytic disorders, hemostasis, thrombosis, and hematologic malignancies. Later chapters review other major subspecialty areas found on the exam including transfusion medicine and hematopoietic cell transplantation. With 200 board-style questions and answers with detailed rationales, Hematology Board Review is the go-to, quick review for any trainee preparing for initial certification and for hematologists or oncologists preparing for recertification.

Key Features:

  • Includes 200 board-style questions and answers with rationales
  • Provides key point summaries of each topic area for quick study and easy recall
  • Thorough coverage of hematologic malignancies, blood disorders, transfusion medicine, hematopoietic cell transplantation, and standard treatment regimens
  • Tables providing key data and information related to staging, treatment options, and disease classifications


فهرست مطالب

Cover
Title
Copyright
Contents
Contributors
Preface
Share Hematology Board Review: Blueprint Study Guide and Q&A
Chapter 1: Normal Hematopoiesis
	Developmental Hematopoiesis
	Hematopoietic Stem Cells
	Hematopoietic Microenvironment
	Assessment of Hematopoiesis
	Questions
	Answers
Chapter 2: Red Blood Cell Production Disorders
	Nutritional Deficiencies
		Epidemiology
		Etiology and Risk Factors
		Signs and Symptoms
		Diagnostic Workup/Criteria
		Treatment
	Anemia of Chronic Disease
		Epidemiology
		Etiology and Risk Factors
		Signs and Symptoms
		Diagnostic Workup/Criteria
		Treatment
	Red Cell Aplasia
		Epidemiology
		Etiology and Risk Factors
		Pathology—Classification
		Signs and Symptoms
		Diagnostic Workup/Criteria
		Prognosis
		Treatment
	Sideroblastic Anemia
		Epidemiology
		Etiology and Risk Factors
		Signs and Symptoms
		Diagnostic Workup/Criteria
		Prognostic Factors
		Treatment
	Congenital Dyserythropoietic Anemias (CDA)
		Epidemiology
		Etiology and Risk Factors
		Signs and Symptoms
		Diagnostic Workup
		Treatment
	Inefficient Erythropoiesis in Thalassemias
		Definition
		Etiology
		Signs and Symptoms
		Diagnostic Workup
		Treatment
		Questions
		Answers
Chapter 3: Red Cell Destruction Disorders
	Warm Antibody Hemolytic Anemia
		Epidemiology
		Etiology and Risk Factors
		Signs and Symptoms
		Diagnostic Criteria
		Treatment
	Cold Agglutinin Disease (CAD)
		Epidemiology
		Staging
		Diagnostic Criteria
		Treatment
	Paroxysmal Nocturnal Hemoglobinuria
		Epidemiology
		Etiology and Risk Factors
		Signs and Symptoms
		Diagnostic Criteria
		Staging
		Prognostic Factors
		Treatment
	Paroxysmal Cold Hemoglobinuria
		Epidemiology
		Treatment
	Metabolic Enzyme Deficiency Hemolytic Anemia
		Glucose 6 Phosphate Dehydrogenase Deficiency
		Treatment
		Pyruvate Kinase Deficiency
		Diagnostic Criteria
		Signs and Symptoms
		Treatment
		Pyrimidine 5\' Nucleotidase (p5\'n-1) Deficiency
	Red Cell Membrane Defects
		Hereditary Spherocytosis
		Diagnostic Criteria
		Signs and Symptoms
		Treatment
		Other Red Cell Membrane Defects
		Questions
		Answers
Chapter 4: The Sickle Cell Syndromes
	Definitions and Nomenclature
	Demographics
	Pathophysiology
	The Sickle Cell Syndromes
	Diagnosis
	Caveats in the Clinical Presentation of the Various Sickle Cell Syndromes
	Management of Acute Episodes
		Management of Acute Chest Syndrome
		Management of Vaso-occlusive Pain Crisis
		Preventive Care in SCD
		Transfusions in Sickle Cell Disease
		Iron Overload in SCD
		Advanced Therapies in SCD
		Questions
		Answers
Chapter 5: White Blood Cell Disorders
	Granulocyte Disorders
		Neutrophil Overview
		Acquired Neutrophil Disorders
		Inherited Neutrophil Disorders
		Treatment of Neutropenia
		Monocyte Overview
		Causes of Monocytosis and Monocytopenia
		Eosinophil Overview
		Causes of Eosinophilia and Eosinopenia
		Basophil Overview
		Causes of Basophilia and Basophilopenia
	Lymphocyte Disorders
		Causes of Lymphopenia and Lymphocytosis
		Questions
		Answers
Chapter 6: Bone Marrow Failure/Aplastic Anemia
	Bone Marrow Failure/Aplastic Anemia
		Definition
		Epidemiology
		Diagnostic Criteria
		Staging
		Signs and Symptoms
		Prognostic Factors
		Treatment
		Questions
		Answers
Chapter 7: Platelet and Megakaryocyte Disorders
	Megakaryocyte and Platelet Overview
	Laboratory Evaluation of Platelets
	Platelet Disorders
	Questions
	Answers
Chapter 8: Hemostasis
	Molecular Basis of Coagulation
	Laboratory Evaluation
	Hereditary Bleeding/Vascular Disorders
	Acquired Bleeding Disorders
	Hemostatic Drugs
	Questions
	Answers
Chapter 9: Thrombosis
	Hereditary Thrombophilias
	Acquired Thrombotic Disorders
	Thrombosis Management
	Thrombosis Complications
	Laboratory Testing and Imaging
	Antiplatelet and Anticoagulant Drugs
	Questions
	Answers
Chapter 10: Myeloproliferative Neoplasms
	Chronic Myelogenous Leukemia (CML)
		Epidemiology
		Etiology and Risk Factors
		Diagnostic Criteria
		Staging
		Signs and Symptoms
		Prognostic Factors
		Treatment
	Myeloproliferative Neoplasms (General)
	Polycythemia Vera
		Epidemiology
		Diagnostic Criteria
		Signs and Symptoms
		Treatment
	Essential Thrombocythemia
		Epidemiology
		Diagnostic Criteria
		Signs and Symptoms
		Treatment
	Primary Myelofibrosis
		Epidemiology
		Diagnostic Criteria
		Signs and Symptoms
		Prognostic Factors
		Treatment
		Questions
		Answers
Chapter 11: Acute Leukemia
	Acute Myeloid Leukemia
		Epidemiology
		Etiology and Risk Factors
		Pathology—Classification
		Signs and Symptoms
		Diagnostic Workup
		Prognostic Factors
		Treatment
	Acute Lymphoblastic Leukemia (ALL)
		Epidemiology
		Etiology and Risk Factors
		Pathology—Classification
		Signs and Symptoms
		Diagnostic Workup
		Prognostic Factors
		Treatment
		Questions
		Answers
Chapter 12: Myelodysplastic Syndromes
	Mylodysplastic Syndromes
		Definition
		Epidemiology
		Etiology, Risk Factors, and Pathogenesis
		Signs and Symptoms
		Diagnosis
		Classification
		Prognostic Factors
		Indications for Treatment
		Treatment
		Chronic Myelomonocytic Leukemia
		Questions
		Answers
Chapter 13: Non-Hodgkin Lymphoma—High Grade
	Epidemiology
	Staging
	Diagnosis
	Diffuse Large B-Cell Lymphoma (DLBCL)
		Epidemiology
		Pathology and Staging
		Prognostic Factors
		Treatment
		Special Considerations
	Burkitt Lymphoma (BL)
		Epidemiology
		Presentation
		Pathology and Staging
		Prognosis
		Treatment
	Mantle Cell Lymphoma (MCL)
		Epidemiology
		Presentation
		Pathology and Staging
		Prognostic Factors
		Treatment
		Questions
		Answers
Chapter 14: Non-Hodgkin Lymphoma—Low Grade
	Epidemiology
	Etiology and Risk Factors
	Staging
	Signs and Symptoms
	Diagnostic Features
	Lymphoplasmacytic Lymphoma/Waldenström’s Macroglobulinemia
		Signs and Symptoms
		Diagnosis
		Treatment
	Chronic Lymphocytic Leukemias
		Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia Diagnosis
		Staging
		Treatment
		Prognosis
		Monoclonal B-Cell Lymphocytosis
	Hairy Cell Leukemia
		Treatment
	Follicular Lymphoma
		Grade and Prognostic Factors
		Treatment
	Marginal Zone Lymphoma
		Signs and Symptoms
		Treatment
		Questions
		Answers
Chapter 15: Multiple Myeloma and Plasma Cell Dyscrasias
	Epidemiology
	Etiology and Risk Factors
	Screening and Diagnostic Criteria
	Pathology
	Signs and Symptoms
	Risk Stratification
	Staging
	Treatment
	Questions
	Answers
Chapter 16: Immunodeficiency-Associated Lymphoproliferative Disorders
	Immunodeficiency-Associated Lymphoproliferative Disorders
		Definition
	Posttransplant Lymphoproliferative Disorders
		Epidemiology
		Etiology and Risk Factors
		Classification
		Signs and Symptoms
		Diagnosis
		Treatment
	AIDS-Related Lymphoma
		Definition
		Epidemiology
		Etiology and Risk Factors
		Classification
		Signs and Symptoms
		Staging
		Diagnosis
		Treatment
	Iatrogenic Immunodeficiency Lymphoproliferative Disorders in Nontransplant Settings
		Definition
		Etiology
		Epidemiology and Risk Factors
		Pathology
		Treatment
		Questions
		Answers
Chapter 17: T-Cell and NK-Cell Neoplasms
	Epidemiology
	Risk Factors
	Signs and Symptoms
	Staging
	Pathology
	Prognostic Factors
	Treatment
	Special Considerations
	Questions
	Answers
Chapter 18: Hodgkin Lymphoma
	Definition/Classification
	Epidemiology
	Etiology and Risk Factors
	Staging
	Signs and Symptoms
	Diagnostic Criteria
	Indications for Treatment
	Prognostic Factors
	Treatment
	Special Considerations
	Questions
	Answers
Chapter 19: Other Neoplasms (Histiocytic and Dendritic Cell Neoplasms, Myeloid and Lymphoid Neoplasms With Eosinophilia)
	Histiocytic Disorders
	Dendritic Cell Neoplasms
	Myeloid and Lymphoid Neoplasms With Eosinophilia
	Questions
	Answers
Chapter 20: Hematologic Emergencies and Supportive Care
	Hematologic Emergencies
		Tumor Lysis Syndrome
		Hyperleukocytosis and Leukostasis
		Urgent/emergent Management of Acute Leukemia
		Febrile Neutropenia
		Chemotherapy Extravasation
	Supportive Care
		Antimicrobial Prophylaxis
		Chemotherapy-Induced Nausea and Vomiting
		Cancer-Associated Venous Thromboembolic Disease
		Pain Management
		Cancer Cachexia
		Dyspnea
		Psychiatric Syndromes
		Questions
		Answers
Chapter 21: Transfusion Medicine
	Blood Products and Transfusion
		Diagnostic Criteria
		Signs and Symptoms
		Risks Associated With Transfusion of Blood Products
		Apheresis
		Risks Associated With Therapeutic Apheresis Procedures
		Questions
		Answers
Chapter 22: Stem Cell Biology and Hematopoiesis
	Questions
	Answers
Chapter 23: Hematopoietic Cell Transplant In the Management of Hematologic Disease
	Questions
	Answers
Chapter 24: Complications After Hematopoietic Cell Transplantation
	Marrow Engraftment Failure
	Graft Versus Host Disease (GVHD)
	Opportunistic Infections
	Hepatic Sinusoidal Obstruction Syndrome
	Management of Relapse
	Late Effects
	Questions
	Answers
Chapter 25: Biostatistics
	Basic Concepts and Definitions
	Diagnostic Tests
	Clinical Trials
	Study Biases
	Questions
	Answers
Index




نظرات کاربران